Teena Banga Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1515 W Main St, Bellville, TX 77418 Phone: 979-865-3689 |
Whitney Mahlmann, MS, SLP-INTERN Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 518 S Mathews St, Bellville, TX 77418 Phone: 979-865-3133 |
Jana Jolan Cornell, SPEECH PATHOLOGIST Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 413 S Tesch St, Bellville, TX 77418 Phone: 979-865-5907 |
News Archive
Brain imaging of pathological tau-protein "tangles" reliably predicts the location of future brain atrophy in Alzheimer's patients a year or more in advance, according to a new study by scientists at the UC San Francisco Memory and Aging Center. In contrast, the location of amyloid "plaques," which have been the focus of Alzheimer's research and drug development for decades, was found to be of little utility in predicting how damage would unfold as the disease progressed.
A commonly used device found in living rooms around the world could be a cheap and effective means of evaluating the walking difficulties of multiple sclerosis (MS) patients.
EKF Diagnostics, announces the availability of a liquid, enzymatic test for glycated albumin that was recently FDA cleared for sales in the U.S.
Sepracor Inc. and Dainippon Sumitomo Pharma Co., Ltd., an Osaka, Japan-based pharmaceutical company, announced today the intent to change the Sepracor name to Sunovion Pharmaceuticals Inc. in the United States. DSP acquired Sepracor in October 2009 and the name change is planned to occur in anticipation of the one-year anniversary of the acquisition. Sepracor intends to begin officially operating as Sunovion Pharmaceuticals Inc. before the end of 2010.
› Verified 2 days ago